학술논문
Dabrafenib plus trametinib in patients with BRAFV600E -mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Document Type
Article
Author
Wen, P.Y.; Stein, A.; van den Bent, M.; De Greve, J.; Wick, A.; de Vos, F.Y.F.L.; von Bubnoff, N.; van Linde, M.E.; Lai, A.; Prager, G.W.; Campone, M.; Fasolo, A.; Lopez-Martin, J.A.; Kim, T.M.; Mason, W.P.; Hofheinz, R.-D.; Blay, J.-Y.; Cho, D.C.; Gazzah, A.; Pouessel, D.; Yachnin, J.; Boran, A.; Ilankumaran, P.; Gasal, E.; Burgess, P.; Subbiah, V.
Source
In: The Lancet Oncology . (The Lancet Oncology, January 2022, 23(1):53-64)
Subject
Language
English
ISSN
14745488
14702045
14702045